These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9785925)

  • 21. Management of the patient with cystinuria.
    Pahira JJ
    Urol Clin North Am; 1987 May; 14(2):339-46. PubMed ID: 3576855
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Slc7a9-deficient mice develop cystinuria non-I and cystine urolithiasis.
    Feliubadaló L; Arbonés ML; Mañas S; Chillarón J; Visa J; Rodés M; Rousaud F; Zorzano A; Palacín M; Nunes V
    Hum Mol Genet; 2003 Sep; 12(17):2097-108. PubMed ID: 12915471
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Beneficial effect of angiotensin converting enzyme inhibitor treatment in severe cystine urolithiasis].
    Rogowska-Kalisz A; Bilińska W; Nowicki M; Olejniczak D; Chilarski A
    Pol Merkur Lekarski; 2003 Mar; 14(81):253-5. PubMed ID: 12914108
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Preoperative diagnosis and postoperative treatment of cystine calculi].
    Deutz H
    Z Urol Nephrol; 1970 Dec; 63(12):891-4. PubMed ID: 5511690
    [No Abstract]   [Full Text] [Related]  

  • 25. [Prevention and dissolution of cystine stones by D-penicillinamine].
    Oliver L; Liberman AU; De Vries A
    Harefuah; 1973 Jan; 84(1):11-3. PubMed ID: 4692793
    [No Abstract]   [Full Text] [Related]  

  • 26. Medicine. Stopping the stones.
    Coe FL; Asplin JR
    Science; 2010 Oct; 330(6002):325-6. PubMed ID: 20947749
    [No Abstract]   [Full Text] [Related]  

  • 27. Antidiuretic hormone antagonist to reduce cystine stone formation.
    de Boer H; Roelofsen A; Janssens PM
    Ann Intern Med; 2012 Sep; 157(6):459-60. PubMed ID: 22986392
    [No Abstract]   [Full Text] [Related]  

  • 28. [Cystinuria: clinical and therapeutic aspects].
    Bruno M; Fruttero B; Marangella M; Linari F
    Boll Chim Farm; 1982 Feb; 121(2):1S-8S. PubMed ID: 7126344
    [No Abstract]   [Full Text] [Related]  

  • 29. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of MPG (2-mercapto-propionyl-glycine) in atrophic enteritis and aregenerative enteropathies.
    Labò G; Gasbarrini G; Barbara L; Fontana G; Corazza GR
    Panminerva Med; 1977; 19(4):227-35. PubMed ID: 593700
    [No Abstract]   [Full Text] [Related]  

  • 31. [ON SOME FINDINGS CONCERNING PATHOLOGICAL AMINOACIDURIAS WITH CYSTINE CALCULOSIS].
    GIOACCHINI B; LOMBARDI R; MEMEO SA
    G Gerontol; 1964 Apr; 12():523-33. PubMed ID: 14185938
    [No Abstract]   [Full Text] [Related]  

  • 32. [Treatment of cystine calculi with mercaptopropionyglycine].
    Thomas J; Charpentier C; Thomas E; Lemonnier A; Steg A; Aboulker P
    Therapie; 1976; 31(5):623-9. PubMed ID: 1013954
    [No Abstract]   [Full Text] [Related]  

  • 33. [Diet therapy in the prevention of renal calculosis].
    Tizzani A; Scaglione C; Cevoli R; Giona C; Frea B
    Minerva Med; 1982 Nov; 73(44):3107-12. PubMed ID: 7145187
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cystine-calculi on unusual form of kidney calculi. Successful treatment in spite of long anamnesis of calculi].
    Griebsch A
    Ther Ggw; 1976 Sep; 115(9):1523-9. PubMed ID: 968784
    [No Abstract]   [Full Text] [Related]  

  • 35. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NTP Toxicology and Carcinogenesis Studies of o-Benzyl-p-Chlorophenol (CAS No. 120-32-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Jan; 424():1-304. PubMed ID: 12616287
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Current aspects of the medical treatment of cystinuria].
    Persu A; Pirson Y
    Acta Urol Belg; 1994 Jun; 62(2):39-44. PubMed ID: 8037002
    [No Abstract]   [Full Text] [Related]  

  • 38. [Cystinuria. Description of a case].
    Barbero S; Domeneghetti G; Sardi R
    Minerva Pediatr; 1979 Feb; 31(3):229-33. PubMed ID: 460080
    [No Abstract]   [Full Text] [Related]  

  • 39. [Prevention of cysteine calculosis by the continuous administration of alpha-mercaptopropionylglycine].
    Berio A
    Minerva Pediatr; 1983 Dec; 35(23-24):1197-1206. PubMed ID: 6425620
    [No Abstract]   [Full Text] [Related]  

  • 40. Cystine growth inhibition through molecular mimicry: a new paradigm for the prevention of crystal diseases.
    Lee MH; Sahota A; Ward MD; Goldfarb DS
    Curr Rheumatol Rep; 2015 May; 17(5):33. PubMed ID: 25874348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.